SCHEMBL23920837

SCHEMBL23920837

COCCNC(=O)CCSc1nc2c(=O)[nH]c(N)nc2n1CCO

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNP P00491 6/20 0.43
SMN1; SMN2 Q16637 4/20 0.37
ATM Q13315 1/20 0.37
TP53 P04637 1/20 0.37
POLB P06746 1/20 0.37
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
HPRT1 P00492 1/20 0.35
USP2 O75604 1/20 0.35
TSHR P16473 1/20 0.35
EDNRA P25101 1/20 0.35
HTR2A P28223 1/20 0.35
RECQL P46063 1/20 0.35
BLM P54132 1/20 0.35
HBB P68871 1/20 0.35
HSD17B10 Q99714 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
HPGD P15428 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23921077 0.94 PNP (0.41) PNPSMN1; SMN2ATMTP53POLB
SCHEMBL23920989 0.91 ATM (0.46) PNPSMN1; SMN2ATMPOLBALDH1A1
SCHEMBL23921134 0.85 PNP (0.46) PNPSMN1; SMN2ALDH1A1HPRT1USP2
SCHEMBL21396401 0.82 PNP (0.42) PNPMAPTHPRT1USP2TSHR
SCHEMBL23921222 0.81 PNP (0.43) PNPALDH1A1MAPTHPRT1USP2
SCHEMBL23921130 0.81 PNP (0.46) PNPMAPTHPRT1USP2TSHR
SCHEMBL23921231 0.81 PNP (0.46) PNPALDH1A1HPRT1USP2TSHR
SCHEMBL23920795 0.81 PNP (0.52) PNPHPRT1USP2TSHREDNRA
SCHEMBL23921227 0.80 ALDH1A1 (0.47) PNPALDH1A1MAPTUSP2TSHR
SCHEMBL23921107 0.79 PNP (0.47) PNPSMN1; SMN2POLBALDH1A1HPRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242568-A1 POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES MIRECA MEDICINES GMBH (DE) 2023-08-03 US disclosed
US-20210317156-A1 NEW POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES MIRECA MEDICINES GMBH (DE) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242568-A1 POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES PRKG1, PRKG2, PRKAG3 PNP 111/4885SMN1; SMN2 4500/4885ATM 1507/4885
US-20210317156-A1 NEW POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES PRKG1, PRKG2, PDE7A PNP 106/4885SMN1; SMN2 4506/4885ATM 1565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.